Literature DB >> 32030274

A cross-sectional evaluation of the idiopathic pulmonary fibrosis patient satisfaction and quality of life with a care coordinator.

Nathan Hambly1,2, Sarah Goodwin1, Afia Aziz-Ur-Rehman1, Nima Makhdami1, Margaret Ainslie-Garcia3, Daniel Grima3, Gerard Cox1,2, Martin Kolb1,2, Diana Fung4, Czerysh Cabalteja4, Patricia DeMarco4, Daniel Moldaver3.   

Abstract

BACKGROUND: Canadian and international guidelines recommend specialized, multidisciplinary teams for the treatment of patients with idiopathic pulmonary fibrosis (IPF). The objective of this cross-sectional clinical study was to investigate the effect of a care coordinator on IPF patient satisfaction and quality of life.
METHODS: Forty IPF patients were enrolled from the practices of two physicians (n=20/physician), with either low (LCU) or high-coordinator use (HCU). Patient satisfaction was measured with modified FAMCARE and IPF Care UK Patient Support Program (UK-CARE) surveys. Health related quality of life (HRQoL) was assessed with the living with IPF impacts (L-IPFi) survey. An economic model assessed the impact of the coordinator; staff surveys informed patient management requirements, and costs were derived from published literature.
RESULTS: Patient satisfaction was similar between the clinics; a trend (P=0.1) towards increased satisfaction among HCU patients was observed. Patients in the HCU clinic reported increased satisfaction (P<0.05) with their current care compared with care prior to joining the tertiary-care clinic, while LCU patients did not. IPF patient HRQoL did not differ between clinics. The coordinator was estimated to alleviate approximately 30% of a physician's IPF-related work load, and to facilitate the care of more patients per physician. Modelled estimates suggest the coordinator lead to annual cost-savings of $137,212.
CONCLUSIONS: Reliance upon a coordinator during routine management of IPF patients may improve patient satisfaction, spare physician time and lead to annual cost-savings. Future studies should examine the impact of a coordinator on healthcare resource utilization. 2019 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  Idiopathic pulmonary fibrosis (IPF); quality of life; satisfaction

Year:  2019        PMID: 32030274      PMCID: PMC6988068          DOI: 10.21037/jtd.2019.11.41

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  18 in total

1.  Psychometric Properties of the Patients' Satisfaction Instrument FAMCARE-P13 in a Palliative Care Unit.

Authors:  Efi Parpa; Natasa Galanopoulou; Eleni Tsilika; Antonis Galanos; Kyriaki Mystakidou
Journal:  Am J Hosp Palliat Care       Date:  2016-04-21       Impact factor: 2.500

Review 2.  Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions.

Authors:  Giovanni Ferrara; Fabrizio Luppi; Surinder S Birring; Stefania Cerri; Antonella Caminati; Magnus Sköld; Michael Kreuter
Journal:  Eur Respir Rev       Date:  2018-02-07

3.  Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada.

Authors:  Robert B Hopkins; Natasha Burke; Charlene Fell; Genevieve Dion; Martin Kolb
Journal:  Eur Respir J       Date:  2016-05-26       Impact factor: 16.671

4.  Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners.

Authors:  Kathleen Oare Lindell; Ellen Olshansky; Mi-Kyung Song; Thomas G Zullo; Kevin F Gibson; Naftali Kaminski; Leslie A Hoffman
Journal:  Heart Lung       Date:  2009-11-20       Impact factor: 2.210

5.  Enhancing cost-effective care with a patient-centric chronic obstructive pulmonary disease program.

Authors:  Chan Chuang; Stuart H Levine; Jeremy Rich
Journal:  Popul Health Manag       Date:  2011-01-08       Impact factor: 2.459

Review 6.  Costs and cost-effectiveness analysis of treatment in children with eczema by nurse practitioner vs. dermatologist: results of a randomized, controlled trial and a review of international costs.

Authors:  M L A Schuttelaar; K M Vermeulen; P J Coenraads
Journal:  Br J Dermatol       Date:  2011-09       Impact factor: 9.302

7.  The Italian version of the FAMCARE scale: a validation study.

Authors:  Rabih Chattat; Giovanni Ottoboni; Anita Zeneli; Maria Alejandra Berardi; Veronica Cossu; Marco Maltoni
Journal:  Support Care Cancer       Date:  2016-04-11       Impact factor: 3.603

Review 8.  IPF Care: a support program for patients with idiopathic pulmonary fibrosis treated with pirfenidone in Europe.

Authors:  Annette Duck; Lucy Pigram; Peter Errhalt; Deeba Ahmed; Nazia Chaudhuri
Journal:  Adv Ther       Date:  2015-02-18       Impact factor: 3.845

9.  The relationship between self-management abilities, quality of chronic care delivery, and wellbeing among patients with chronic obstructive pulmonary disease in The Netherlands.

Authors:  Jane Murray Cramm; Anna Petra Nieboer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-04-26

10.  Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients' perspectives of the disease and treatment.

Authors:  Anne-Marie Russell; Elena Ripamonti; Carlo Vancheri
Journal:  BMC Pulm Med       Date:  2016-01-14       Impact factor: 3.317

View more
  4 in total

1.  Idiopathic pulmonary fibrosis management: caring is sparing.

Authors:  Stefano Nava; Irene Prediletto
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

2.  Beyond standard care?-idiopathic pulmonary fibrosis patients' perception of care coordinators.

Authors:  Lars Hagmeyer; Winfried Randerath
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895

3.  Care programs and their components for patients with idiopathic pulmonary fibrosis: a systematic review.

Authors:  Anouk Delameillieure; Sarah Vandekerkhof; Bastiaan Van Grootven; Wim A Wuyts; Fabienne Dobbels
Journal:  Respir Res       Date:  2021-08-16

4.  Ligustilide modulates oxidative stress, apoptosis, and immunity to avoid pathological damages in bleomycin induced pulmonary fibrosis rats via inactivating TLR4/MyD88/NF-KB P65.

Authors:  Shu Luo; Junzuo Gong; Xiaoping Cao; Shiping Liu
Journal:  Ann Transl Med       Date:  2020-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.